IFRS earnings per share growth vs Novel active substance launches
IFRS earnings per share growth and Novel active substance launches worldwide, compared over time.
Change the pair
Compare different indicators
The series
Over time
Global, spaced by time . Different units, drawn on separate scales and clipped to the years both series publish — earlier history stays on each indicator's own page. Read the values, not the heights.
IFRS earnings per share growth
Unit: % · 2 observations
Novel active substance launches
Unit: count · 2 observations
Provenance
Where these numbers come from
IFRS earnings per share growth
Percentage change in IFRS earnings per share compared to the prior-year period.
2 observations in Global · source organisations: Sanofi
Novel active substance launches
Total number of novel active substances launched.
2 observations in Global · source organisations: IFPMA, IQVIA
Data published under CC BY 4.0. Series A as JSON · Series B as JSON
Keep exploring